Medtronic Inc. (NYSE:MDT) said Friday a pivotal clinical trial testing its experimental Endurant stent showed promising results in treating abdominal aortic aneurysms after one year. The company based ...

Back in April 2015, Medtronic ($MDT) launched a clinical study of its Endurant Evo AAA stent graft system. Now, the company is suspending recruitment on the trial ...

Medtronic received a breakthrough designation from the FDA for its combination stent-graft system designed to seal off large aortic aneurysms that span from the chest down into the abdomen. The ...

An abdominal aortic aneurysm (AAA) is a bulging, weak point in the aorta—the main trunk of the arterial system. The condition potentially is life threatening. If the aneurysm bursts and is not treated ...

A new stent graft made from a 3-D image of the patient’s anatomy helps fix abdominal aortic aneurysms in patient's who otherwise have few options. An abdominal aortic aneurysm is an enlarged area in ...

Many patients who need surgery to repair an abdominal aortic aneurysm are recovering much faster and experiencing much less pain because of a relatively new grafting procedure performed at Methodist ...

Abdominal aortic aneurysms are significantly more common, with 200,000 people in the U.S. diagnosed each year. Here's what to ...

Abdominal aortic aneurysm is a life-threatening cardiovascular disease characterized by chronic inflammation and irreversible dilatation of the abdominal aorta and is asymptomatic at the early stages ...

A US-based hospital will be testing a new device known as a multilayer stent in patients suffering from aortic aneurysm. Approved in Europe in 2010, the device has already been used to help hundreds ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced that it has received both FDA approval and a CE mark for its Endurant IIs AAA stent graft, ...